Disease Info Card

Fenestration (morphologic Abnormality)

Information about Fenestration (morphologic Abnormality): characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Fenestration (morphologic Abnormality)

Most recent studies have shown that Fenestration (morphologic Abnormality) shares some biological mechanisms with aneurysm, aneurysm-dissecting, aortic-aneurysm, arachnoid-cysts, congenital-heart-defects, dissection-of-aorta, headache, hemorrhage, hydrocephalus, hypertensive-disease, intracranial-aneurysm, intracranial-hypertension, ischemia, liver-diseases, neoplasms, otosclerosis, pain, stenosis, subarachnoid-hemorrhage.

Among the many pathways, these few ones have gauged particular interests from scientists studying Fenestration (morphologic Abnormality), and have been seen in publications frequently: Acrosome Reaction, Aging, Angiogenesis, Coagulation, Dehiscence, Enucleation, Fertilization, Glomerular Filtration, Hemostasis, Interphase, Localization, Mitosis, Pathogenesis, Reflex, Regeneration, Secretion, Tissue Regeneration, Transport, Transposition, Wound Healing

Quite a number of genes have been found to play important roles in Fenestration (morphologic Abnormality), such as ALB, AMY2A, ATP6V0A1, BLOC1S6, C2, CLIP1, CLIP2, CSF2, HNRNPC, ICA, LAMC2, POMC, RFC1, RFC2, RFC4, SLC17A5, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Fenestration (morphologic Abnormality) Related Genes

click to see detail information for each gene

ALB AMY2A ATP6V0A1
BLOC1S6 C2 CLIP1
CLIP2 CSF2 HNRNPC
ICA LAMC2 POMC
RFC1 RFC2 RFC4
SLC17A5 VEGFA